• 3519 Citations
  • 23 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where John Christopher Morgan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Levodopa Medicine & Life Sciences
Tremor Medicine & Life Sciences
Movement Disorders Medicine & Life Sciences
Magnetic Resonance Imaging Medicine & Life Sciences
Parkinsonian Disorders Medicine & Life Sciences
Drug Dose Response Relationship Medicine & Life Sciences
Chorea Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

Treatment of tardive akathisia

Morgan, J. C., Jan 1 2019, Current Clinical Neurology. Humana Press Inc., p. 297-299 3 p. (Current Clinical Neurology).

Research output: Chapter in Book/Report/Conference proceedingChapter

Drug-Induced Akathisia
Dopamine Receptors
Psychomotor Agitation
Adrenergic Antagonists

Bilateral facial spasm following guillain–barrésyndrome

Guduru, Z., Morgan, J. C. & Sethi, K., Jan 1 2018, In : Tremor and Other Hyperkinetic Movements. 8

Research output: Contribution to journalArticle

Facial Muscles
Nerve Fibers
1 Citation (Scopus)
Parkinson Disease
Prodromal Symptoms
2 Citations (Scopus)

Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor Fluctuations

Morgan, J. C., Dhall, R., Rubens, R., Khanna, S. & Gupta, S., Jan 1 2018, In : Parkinson's Disease. 2018, 9763057.

Research output: Contribution to journalArticle

Parkinson Disease
levodopa drug combination carbidopa
Random Allocation
6 Citations (Scopus)

Niacin modulates macrophage polarization in Parkinson's disease

Wakade, C. G., Giri, B., Malik, A., Khodadadi, H., Morgan, J. C., Chong, K. Y. R. & Baban, B., Jul 15 2018, In : Journal of Neuroimmunology. 320, p. 76-79 4 p.

Research output: Contribution to journalArticle

Parkinson Disease
Anti-Inflammatory Agents
Disease Progression